Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 32 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humansWu, T.; Bound, M.; Standfield, S.; Gedulin, B.; Jones, K.; Horowitz, M.; Rayner, C.
2014Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metforminWu, T.; Ma, J.; Bound, M.; Checklin, H.; Deacon, C.; Jones, K.; Horowitz, M.; Rayner, C.
2016Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trialThazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Standfield, S.; Jones, K.; Horowitz, M.; Rayner, C.
2019Comparative effects of proximal and distal small intestinal glucose exposure on glycemia, incretin hormone secretion, and the incretin effect in health and type 2 diabetesZhang, X.; Young, R.L.; Bound, M.; Hu, S.; Jones, K.L.; Horowitz, M.; Rayner, C.K.; Wu, T.
2016A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetesWu, T.; Little, T.; Bound, M.; Borg, M.; Zhang, X.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2016Small intestinal glucose delivery affects the lowering of blood glucose by acute vildagliptin in type 2 diabetesWu, T.; Zhang, X.; Trahair, L.; Bound, M.; Little, T.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2015Effects of sitagliptin on blood pressure and heart rate in response to intraduodenal glucose infusion in patients with Type 2 diabetes: a potential role for glucose-dependent insulinotropic polypeptide?Wu, T.; Trahair, L.; Bound, M.; Deacon, C.; Horowitz, M.; Rayner, C.; Jones, K.
2016The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trialThazhath, S.; Marathe, C.; Wu, T.; Chang, J.; Khoo, J.; Kuo, P.; Checklin, H.; Bound, M.; Rigda, R.; Crouch, B.; Jones, K.; Horowitz, M.; Rayner, C.
2012Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humansWu, T.; Zhao, R.; Bound, M.; Checklin, H.; Bellon, M.; Little, T.; Young, R.; Jones, K.; Horowitz, M.; Rayner, C.
2013Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetesWu, T.; Bound, M.; Zhao, R.; Standfield, S.; Bellon, M.; Jones, K.; Horowitz, M.; Rayner, C.